jsmc-10166

PREVALENCE OF VITAMIN D DEFICIENCY IN DIABETIC PATIENTS

Taha Mahwi a and Rawand M. Raouf b

a Department of Medicine, College of Medicine, University of Sulaimani.

b Kurdistan Board of Medical Specialties Candidate.

Submitted: 6/3/2018; Accepted: 5/8/2018; Published 15/10/2018

DOI Link: https://doi.org/10.17656/jsmc.10166

ABSTRACT

Background

There are increasing incidence of diabetes around the worldwide, and there are a lot of studies have been considering vitamin D’s role in the incidence, and improving glucose status in diabetes.

Objectives

This study is done to evaluate the prevalence of vitamin D deficiency in diabetic patients in Sulaimani Diabetes and Endocrine Center.

Materials and Methods

This is a case-control study done on 100 diabetic patients compared to 100 persons in the general population in Sulaimani/Iraq. Their Vitamin D was estimated from June 1st, 2017 to December 1st, 2017.

Results

Results: The mean age of the diabetic group was (49.68 yr. ± 8.64 SD), and the mean age of the non-diabetic group was (50.49 yr. ±6.78 SD). The mean vitamin D’s level in the diabetic group was (16.91 ng/dl ± 5.5 SD) and in a non-diabetic group was (16.21 ng/dl ±8.59) (P-values= 0.493). Among diabetic group vitamin D level is significantly higher in males with an average of 6.2 mg/dl in comparison to females, (P-Value = 0.024), among diabetic patients, Vitamin D level was deficient in (66%), insufficient in (19%) and was sufficient just in (15%), while in non-diabetic control group vitamin D level was deficient in (77%), insufficient in (20%) and sufficient just in (3%). The P-value for these differences is (0.0052).

Conclusion

The results of this study show the majority of our participants have suboptimal vitamin D level. Vitamin D level was lower in female patients in comparison to male patients.

KEYWORDS

Diabetes Mellitus (DM), Vitamin D deficiency, Serum Vitamin D.

References

1. Sherwin, R.; Jastreboff, A.M. Year in diabetes 2012: the diabetes tsunami. J. Clin. Endocrinol. Metab. 2012, 97,4293–4301

2. Zella JB, DeLuca HF. Vitamin D and autoimmune diabetes. J Cell Biochem 2003; 88: 216-22.

3. Motlagh B, O’Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009;16(3):268–80.

4. Al Zenki S, Al Omirah H, Al Hooti S, Al Hamad N, Jackson RT, Rao A, et al. High prevalence of metabolic syndrome among Kuwaiti adults–a wake-up call for public health intervention. Int J Environ Res Public Health. 2012;9(5):1984–96.

5. Gaugris S, Heaney RP, Boonen S, Kurth H, Bentkover JD, Sen SS.Vitamin D inadequacy among post-menopausal women: a systematic review.QJM. 2005;98:667-676.

6. Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S.Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int. 2003;14:577-582.

7. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc.2003;78:1463-1470

8. Carnevale V, Manfredi G, Romagnoli E, et al. Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin Endocrinol (Oxf). 2004;60:81-86

9. Harwood RH, Sahota O, Gaynor K, Masud T, Hosking DJ. A randomized, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham Neck of Femur (NONOF) Study. Age Ageing. 2004;33:45-51

10. Glowacki J, Hurwitz S, Thornhill TS, Kelly M, LeBoff MS. Osteoporosis and vitamin-D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty. J Bone Joint Surg Am. 2003;85-A:2371-2377

11. Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, Diaz-Lopez JB, Fernandez-Coto MT, Cannata-Andia JB. Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels.Kidney Int Suppl. 2003;85: S44-S48.

12. Blau EM, Brenneman SK, Bruning AL, Chen Y. Prevalence of vitamin D insufficiency in an osteoporosis population in Southern California [abstract]. J Bone Miner Res. 2004;19(suppl 1): S342. Abstract SU582.

13. Simonelli C, Weiss TW, Morancey J, Swanson L, Chen YT. Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res Opin. 2005;21:1069-1074.

14. Al-Hilali, K. A.; Prevalence of Hypovitaminosis D in Adult Iraqi People Including Postmenopausal Women; Scientific Research Journal (SCIRJ), Volume IV, Issue IX, September 2016

15. Binkley N, Ramamurthy R, Krueger D. Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am.2010;39:287-301

16. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18–28.

17. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81:353–373.

18. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S, Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006; 29:722–724.

19. Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006; 29:2244–2246.

20. Aksoy H, Akcay F, Kurtul N, Baykal O, Avci B. Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxyvitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem 2000; 33:47–51.

21. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001; 24:1496.

22. Ishida H, Seino Y, Matsukura S, Ikeda M, Yawata M, Yamashita G, et al. Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetes. Metabolism 1985; 34:797–801

23. Lambert PW, Service FJ, Arnaud SB. Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab 1979; 49:462–466.

24. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008; 93: 512-7.

25. Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1, 25 dihydroxy vitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 1999; 160: 87-95.

26. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D.Vitamin D, glucose tolerance and insulinemia in elderly men. Diabetologia 1997; 40: 344-7.

27. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30: 980-6.

28. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring Diabetologia 2000; 43:1093-8.

29. Tangpricha V, Pearce EN, Chen TC, Holick MF. VitaminD insufficiency among free-living healthy young adults. Am J Med 2002; 112: 659-62.

30. Daga RA, Laway BA, Shah ZA, et al. High prevalence of vitamin D deficiency among newly diagnosed youth-onset diabetes mellitus in north India. Arq Bras Endocrinol Metabol 2012; 56: 423-8.

31. Bayani MA, Banasaz B, Saeedi F. Status of Vitamin-D in diabetic patients and compared it with healthy individuals. Caspian J Intern Med 2014; 5(1): 40-42.

32. Al-Zaharani M. Prevalence of Vitamin D Deficiency in type 2 DM patients. Majmaah J. Health Sciences 2013;1(1): 24-28

33. Al-Horani, Hanan et al. Nationality, Gender, Age, and Body Mass Index Influences on Vitamin D Concentration among Elderly Patients and Young Iraqi and Jordanian in Jordan. Biochemistry Research International 2016 (2016): 8920503

34. Sinem BOZKURT, Berat Meryem ALKAN, Fatma YILDIZ, et al. Age, Sex, and Seasonal Variations in the Serum Vitamin D3 Levels in a Local Turkish Population. Turkish League Against Rheumatism, 2014; 29(1): 014-019

35. Madar AA, Knutsen KV, Stene LC, et al. Effect of vitamin D3 supplementation on glycated hemoglobin (HbA1c), fructosamine, serum lipids, and body mass index: a randomized, double-blinded, placebo-controlled trial among healthy immigrants living in Norway. BMJ Open Diabetes Research and Care 2014;2:e000026.

Full Text

This work is licensed under a Creative Commons Attribution 4.0 International License.